12/10/2017: CORPORATE: Lupin buys US firm Symbiomix for $150 million

Published: 12/10/2017
12/10/2017: CORPORATE: Lupin buys US firm Symbiomix for $150 million
Source: EPAPER.LIVEMINT.COM

Lupin Ltd on Wednesday said its US subsidiary has acquired Symbiomix Therapeutics LLC for a cash consideration of $150 million, in a bid to expand in the women’s health segment. The total cash consideration includes an upfront payment of $50 million...

Read more
Related news
Comment